At 10:08 am on August 6, 2019, the signing ceremony for the acquisition of Liaoning Xinkang Pharmaceutical Co.,Ltd. by Shanghai Pharmaceutical Liaoning Pharmaceutical Foreign Trade Corporation was held in our conference room.
Mr. Yuan Kehua, general manager of Shanghai Pharmaceutical Group Liaoning Pharmaceutical Foreign Trade Corporation and members of the leadership team, as well as Mr. Sun Haibo, the representative of shareholders of Liaoning Xinkang Pharmaceutical Co., Ltd., attended the signing ceremony.
At the signing ceremony, General Manager Yuan Kehua highly affirmed the sincerity of cooperation shown by Liaoning Xinkang Pharmaceutical Co., Ltd. and its shareholders in the acquisition process, and expressed gratitude for the support and attention from the leaders of Shanghai Pharmaceutical Keyuan and Shanghai Pharmaceutical Group. Mr. Sun Haibo said that he was very honored to join the family of Shanghai Pharmaceuticals. The successful reorganization provided a historical opportunity for the company to realize rapid development. The new company will strictly comply with the requirements of Shanghai Pharmaceutical Group Liaoning Pharmaceutical Foreign Trade Corporation and Shanghai Pharmaceutical Management System, and operate in compliance with laws and regulations to ensure the completion of the expected business goals.
Up to now, Liaoning Xinkang Pharmaceutical Co., Ltd. has officially become a new member of Liaoning Provincial Platform of Shanghai Pharmaceuticals, and its name is changed to Shanghai Pharmaceutical Group (Faku) Pharmaceutical Co., Ltd. General Manager Yuan Kehua welcomed Liaoning Xinkang Pharmaceutical Co., Ltd. to join the Shanghai family of pharmaceuticals on behalf of all the employees of Shanghai Pharmaceutical Group Liaoning Pharmaceutical Foreign Trade Corporation, and raised expectations and requirements for the development of the new company. At the same time, he said that he would give full support to the new company. Relying on the comprehensive resource allocation capabilities, advanced logistics supply chain services and the sales system covering a large number of grassroots medical outlets of Shanghai Pharmaceutical Group Liaoning Pharmaceutical Foreign Trade Corporation, Shanghai Pharmaceutical Group (Faku) Pharmaceutical Co., Ltd. will definitely become a new pharmaceutical circulation platform with advanced business philosophy and intelligent service capabilities.
General Manager Yuan Kehua pointed out that Shanghai Pharmaceutical Group (Faku) Pharmaceutical Co., Ltd. should fully implement the content of the agreement. Through continuous exploration, continuous innovation and continuous upgrading, Shanghai Pharmaceutical Group (Faku) Pharmaceutical Co., Ltd. would serve the people wholeheartedly and make contributions to the national health.
The successful acquisition of Liaoning Xinkang Pharmaceutical Co., Ltd. is a milestone in the development history of Shanghai Pharmaceutical Group Liaoning Pharmaceutical Foreign Trade Corporation, and is also the first step in the strategic layout of the regional pharmaceutical market of Shanghai Pharmaceutical Liaoning Provincial Platform. It makes Shanghai Pharmaceuticals Group more competitive in the pharmaceutical field of Liaoning, and it also reflects Shanghai Pharmaceutical’s determination to serve people’s livelihood and contribute to graded medical treatment. As General Manager Yuan Kehua said, “This acquisition is an arduous task and a glorious mission!” This successful acquisition is a good start for the overall layout. For the next step, as long as everyone unites and helps each other with the same goal, completes all business indicators and tasks with high quality and quantity, Liaoning Foreign Trade and Shanghai Pharmaceuticals (Faku) will surely go further and achieve greater results!